News

Regeneron Pharmaceuticals has entered into a strategic research collaboration with Parabilis Medicines to discover and develop a new class of therapeutics designed to target…
Read More...

VERTANICAL said the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to VER-01, the company’s investigational non-opioid treatment for chronic low back…
Read More...

Owkin has entered into a new multi-year agreement with AstraZeneca to develop specialized artificial intelligence agents designed to support biopharmaceutical decision-making and…
Read More...

AstraZeneca announced positive interim results from the Phase III VOLGA clinical trial, showing that perioperative treatment with Imfinzi combined with neoadjuvant enfortumab vedotin…
Read More...

Arna Pharma Inc. and Slate Run Pharmaceuticals have officially finalized a joint venture aimed at creating a larger U.S.-based specialty pharmaceutical company focused on branded…
Read More...

Bristol Myers Squibb and Hengrui Pharma have entered into a broad strategic collaboration and licensing agreement focused on developing innovative medicines across oncology, hematology,…
Read More...

Pfizer Inc. announced that the European Commission has approved an expanded indication for HYMPAVZI, allowing its use in patients aged 12 years and older with hemophilia A or hemophilia…
Read More...

Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. announced updated clinical data from the frontline arm of the Phase 1 KOMET-007 trial evaluating Ziftomenib in combination with intensive…
Read More...

Assertio Holdings, Inc. announced that its Board of Directors has approved a definitive agreement for Zydus Lifesciences Limited, through its subsidiary Zydus Worldwide DMCC, to acquire…
Read More...

Zai Lab Limited announced that the U.S. Food and Drug Administration has granted Fast Track Designation to Zocilurtatug pelitecan, also known as zoci and formerly identified as ZL-1310,…
Read More...

Isomorphic Labs announced that it has secured $2.1 billion in Series B financing to expand its artificial intelligence-powered drug discovery and development platform, marking one of…
Read More...

New Phase III clinical trial results presented at the European Congress of Endocrinology in Prague showed that Eneboparatide achieved significant improvements in calcium regulation and…
Read More...

GSK has announced an exclusive strategic collaboration with Sino Biopharmaceutical through its subsidiary Chia Tai Tianqing Pharmaceutical Group to accelerate the launch and…
Read More...

Bristol Myers Squibb announced that the European Commission has approved Sotyktu for the treatment of adults with active psoriatic arthritis (PsA) who have had an inadequate response or…
Read More...

The U.S. Food and Drug Administration has launched a new initiative aimed at accelerating the development of treatments for patients with unmet medical needs by exploring new uses for…
Read More...

Partner Therapeutics announced that the U.S. Food and Drug Administration has approved BIZENGRI for the treatment of adults with advanced, unresectable, or metastatic cholangiocarcinoma…
Read More...

Swiss healthcare giant Roche has signed a definitive merger agreement to acquire U.S.-based artificial intelligence pathology company PathAI, strengthening its position in the rapidly…
Read More...

Altasciences and Certara have announced a strategic partnership aimed at accelerating early-stage drug development by integrating advanced modeling and simulation technologies into…
Read More...

Italian drugmaker Angelini Pharma has agreed to acquire U.S.-based rare disease specialist Catalyst Pharmaceuticals in a cash transaction valued at approximately $4.1 billion, marking…
Read More...

Novartis has begun construction on a new radioligand therapy (RLT) manufacturing facility in Denton, Texas, as part of the company’s expanding multibillion-dollar investment in U.S.…
Read More...